Two experts, Dr. Meryl Nass and Robert Kennedy have highlighted the serious known risks of immediate harm and the unknown long-term risks from COVID vaccines to children.
In a letter to the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC), the duo on behalf of of Children’s Health Defense (CHD) highlighted peer-reviewed research showing children have virtually zero risk of hospitalization and death from COVID.
The letter highlights the latest peer-reviewed research showing children have virtually zero risk of hospitalization and death from the COVID-19 virus. Furthermore, it outlines the serious known risks of immediate harm and the unknown long-term risks from the vaccines to children.
The FDA’s VRBPAC committee meets Tuesday, Oct. 26, to vote to authorize Pfizer’s COVID vaccine for children aged 5 to 11.
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) will meet Nov. 2-3 to consider recommending the same Emergency Use Authorization (EUA) vaccine.
If both expert committees, the FDA and the Centers for Disease Control and Prevention, endorse the EUA vaccine, as appears highly likely, then millions of young children in the U.S. and around the world immediately will begin to receive them.
According to the experts, it is critically important that the letter reaches all members of the U.S. House of Representatives and Senate so they are aware of the threat COVID vaccines pose to the health of young children.